Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, FY2025
11,813
Period ended Dec 31, 2025
Change on a year earlier
-1.6%
12,004 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total current liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,813 | -1.6% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 12,004 | +6.4% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 11,280 | +0.4% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 11,237 | -3.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 11,610 | +1.9% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 11,397 | +16.8% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 9,759 | -8.0% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 10,605 | -8.9% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 11,635 | +26.2% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 9,218 | -6.8% | Form 10-Q (filed 2017-05-10) ↗ |
| FY2015 | Dec 31, 2015 | 9,890 | +71.7% | Form 10-Q (filed 2016-05-06) ↗ |
| FY2014 | Dec 31, 2014 | 5,761 | -10.1% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 6,407 | +51.2% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 4,238 | +68.5% | Form 10-K (filed 2014-02-25) ↗ |
| FY2011 | Dec 31, 2011 | 2,515 | +2.0% | Form 10-K (filed 2012-02-23) ↗ |
| FY2010 | Dec 31, 2010 | 2,465 | +31.7% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 1,872 | +53.3% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 1,221 | – | Form 10-Q (filed 2009-08-05) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Total current liabilities ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_tcl
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.